ScholarIQanswers from OpenAlex & ORCID
Suzanne Oparil
ResearcherPublications, citations & collaboration network
Suzanne Oparil is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Suzanne Oparil have?
ScholarIQindexed works
Suzanne Oparil has 1,165 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Suzanne Oparil have?
ScholarIQcitation count
Suzanne Oparil has 68,363 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Suzanne Oparil?
ScholarIQh-index
Suzanne Oparil has an h-index of 106 in OpenAlex.
What is the i10-index of Suzanne Oparil?
ScholarIQi10-index
Suzanne Oparil has an i10-index of 601 in OpenAlex.
What is the ORCID of Suzanne Oparil?
ScholarIQorcid
The ORCID for Suzanne Oparil is on the source record.
What is the OpenAlex record for Suzanne Oparil?
ScholarIQopenalex
The OpenAlex for Suzanne Oparil is on the source record.
What are the most-cited papers on Suzanne Oparil?
ScholarIQmost cited works
2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults
Paul A. James, Suzanne Oparil, Barry L. Carter, William C. Cushman, Cheryl Dennison Himmelfarb, Joel Handler, Daniel T. Lackland, Michael Lefevre, Thomas D. MacKenzie, Olugbenga Ogedegbe, Sidney C. Smith, Laura P. Svetkey, Sandra J. Taler, Raymond R. Townsend, Jackson T. Wright, Andrew S. Narva, Eduardo Ortíz
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol
Björn Dahlöf, Richard B. Devereux, Sverre E. Kjeldsen, Stevo Julius, Gareth Beevers, Ulf dé Fairé, Frej Fyhrquist, Hans Ibsen, Krister Kristiansson, Ole Lederballe‐Pedersen, Lars Lindholm, Markku S. Nieminen, Per Omvik, Suzanne Oparil, Hans Wedel
A Controlled Trial of Renal Denervation for Resistant Hypertension
Deepak L. Bhatt, David E. Kandzari, William W. O’Neill, Ralph B. D’Agostino, John M. Flack, Barry T. Katzen, Martin B. Leon, Minglei Liu, Laura Mauri, Manuela Negoita, Sidney A. Cohen, Suzanne Oparil, Krishna J. Rocha‐Singh, Raymond R. Townsend, George L. Bakris
Effectiveness-Based Guidelines for the Prevention of Cardiovascular Disease in Women—2011 Update
Lori Mosca, Emelia J. Benjamin, Kathy Berra, Judy L. Bezanson, Rowena J Dolor, Donald M. Lloyd‐Jones, L. Kristin Newby, Ileana L. Piña, Véronique L. Roger, Leslee J. Shaw, Dong Zhao, Theresa M. Beckie, Cheryl Bushnell, Jeanine D’Armiento, Penny M. Kris‐Etherton, Jing Fang, Théodore G. Ganiats, Antoinette S. Gomes, Clarisa R. Gracia, Constance K. Haan, Elizabeth A. Jackson, Debra R. Judelson, Ellie Kelepouris, Carl J. Lavie, Anne Moore, Nancy A. Nussmeier, Elizabeth Ofili, Suzanne Oparil, Pamela Ouyang, Vivian W. Pinn, Katherine Sherif, Sidney C. Smith, George Sopko, Nisha Chandra‐Strobos, Elaine M. Urbina, Viola Vaccarino, Nanette K. Wenger
Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol
Lars Lindholm, Hans Ibsen, Björn Dahlöf, Richard B. Devereux, Gareth Beevers, Ulf dé Fairé, Frej Fyhrquist, Stevo Julius, Sverre E. Kjeldsen, Krister Kristiansson, Ole Lederballe‐Pedersen, Markku S. Nieminen, Per Omvik, Suzanne Oparil, Hans Wedel, Peter Aurup, Jonathan M. Edelman, Steven Snapinn